Estudo sugere que a síndrome inflamatória multissistêmica em crianças (MIS-C) é rara entre adolescentes vacinados.
25 Fev, 2022 | 14:22hComentários:
When vaccine adverse event reporting generates hope, not fear – The Lancet Child & Adolescent Health
MIS-C rare in COVID-vaccinated teens, study finds – CIDRAP
Vaccination Greatly Reduces Odds of MIS-C in Teens Who Get COVID – HealthDay
Comentário no Twitter
New study from @CDCgov finds that multi-system inflammatory syndrome in children (#MISC) is rare among 12 to 20-year-olds who have received #COVID19 vaccination (1.0 case per million individuals receiving one or more doses)https://t.co/BpsXSpMMcH
— The Lancet Child & Adolescent Health (@LancetChildAdol) February 23, 2022